These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14981182)

  • 21. Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent
    Wood ET; Ercan E; Sati P; Cortese ICM; Ronen I; Reich DS
    Neuroimage Clin; 2017; 15():780-788. PubMed ID: 28702353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.
    Matthews PM; Pioro E; Narayanan S; De Stefano N; Fu L; Francis G; Antel J; Wolfson C; Arnold DL
    Brain; 1996 Jun; 119 ( Pt 3)():715-22. PubMed ID: 8673485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM
    J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
    BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease.
    Arnold DL; Matthews PM; Francis G; Antel J
    Magn Reson Med; 1990 Apr; 14(1):154-9. PubMed ID: 2161982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences.
    Bjartmar C; Trapp BD
    Curr Opin Neurol; 2001 Jun; 14(3):271-8. PubMed ID: 11371748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
    Arnold DL; Riess GT; Matthews PM; Francis GS; Collins DL; Wolfson C; Antel JP
    Ann Neurol; 1994 Jul; 36(1):76-82. PubMed ID: 8024266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
    Filippi M; Rocca MA; Pagani E; De Stefano N; Jeffery D; Kappos L; Montalban X; Boyko AN; Comi G;
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):851-8. PubMed ID: 24029546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.
    Pelletier D; Nelson SJ; Oh J; Antel JP; Kita M; Zamvil SS; Goodkin DE
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):950-2. PubMed ID: 12810788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of the whole-brain N-acetylaspartate level across institutions, MR scanners, and field strengths.
    Benedetti B; Rigotti DJ; Liu S; Filippi M; Grossman RI; Gonen O
    AJNR Am J Neuroradiol; 2007 Jan; 28(1):72-5. PubMed ID: 17213427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated whole-brain N-acetylaspartate proton MRS quantification.
    Soher BJ; Wu WE; Tal A; Storey P; Zhang K; Babb JS; Kirov II; Lui YW; Gonen O
    NMR Biomed; 2014 Nov; 27(11):1275-84. PubMed ID: 25196714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axonal damage in multiple sclerosis patients with high versus low expanded disability status scale score.
    Brass SD; Narayanan S; Antel JP; Lapierre Y; Collins L; Arnold DL
    Can J Neurol Sci; 2004 May; 31(2):225-8. PubMed ID: 15198448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: a preliminary study.
    Inglese M; Brown S; Johnson G; Law M; Knopp E; Gonen O
    AJNR Am J Neuroradiol; 2006; 27(10):2137-40. PubMed ID: 17110683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging neuronal and axonal degeneration in multiple sclerosis.
    De Stefano N; Guidi L; Stromillo ML; Bartolozzi ML; Federico A
    Neurol Sci; 2003 Dec; 24 Suppl 5():S283-6. PubMed ID: 14652790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study.
    Takado Y; Igarashi H; Terajima K; Shimohata T; Ozawa T; Okamoto K; Nishizawa M; Nakada T
    Mov Disord; 2011 Jun; 26(7):1297-302. PubMed ID: 21370263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.
    De Stefano N; Dotti MT; Mortilla M; Federico A
    Brain; 2001 Jan; 124(Pt 1):121-31. PubMed ID: 11133792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy.
    Cohen BA; Knopp EA; Rusinek H; Babb JS; Zagzag D; Gonen O
    AJNR Am J Neuroradiol; 2005 Oct; 26(9):2170-7. PubMed ID: 16219818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
    J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.